Analysis reveals weaknesses in health security affecting Mpox management in Africa, indicating urgent vaccination needs.
Weak surveillance capacity was evident as African countries appeared to have relaxed health security and outbreaks response strategies post-COVID-19 pandemic. Scale-up of vaccination uptake against the Mpox virus is required, particularly for clades Ia, Ib, and II, to prevent Mpox spread and mortality. A consistent multi-country surveillance will be critical to contain Mpox epidemics.
No takes yet. Share an insight, caveat, or question.
Oyedele et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: